KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $274.7 million.

  • Edwards Lifesciences' Long-Term Investments fell 1404.88% to $274.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $274.7 million, marking a year-over-year decrease of 1404.88%. This contributed to the annual value of $307.9 million for FY2024, which is 4726.84% down from last year.
  • According to the latest figures from Q3 2025, Edwards Lifesciences' Long-Term Investments is $274.7 million, which was down 1404.88% from $298.5 million recorded in Q2 2025.
  • Over the past 5 years, Edwards Lifesciences' Long-Term Investments peaked at $1.8 billion during Q4 2021, and registered a low of $274.7 million during Q3 2025.
  • In the last 5 years, Edwards Lifesciences' Long-Term Investments had a median value of $802.2 million in 2021 and averaged $850.8 million.
  • Its Long-Term Investments has fluctuated over the past 5 years, first surged by 12881.74% in 2021, then crashed by 5873.63% in 2024.
  • Quarter analysis of 5 years shows Edwards Lifesciences' Long-Term Investments stood at $1.8 billion in 2021, then plummeted by 32.45% to $1.2 billion in 2022, then tumbled by 52.87% to $583.9 million in 2023, then plummeted by 47.27% to $307.9 million in 2024, then dropped by 10.78% to $274.7 million in 2025.
  • Its Long-Term Investments stands at $274.7 million for Q3 2025, versus $298.5 million for Q2 2025 and $277.9 million for Q1 2025.